Product Name	Percentage	Mesh Size	Release Type	Target Formulations
Aprepitant Pellets	15% , 40%	-	Immediate Release	Capsules \| Injectables
Azithromycin MUPS & Granules	20% , 40% , 7.5%	-	Tastemasked	Capsules \| Suspension \| Tablets
Brinzolamide Opthalmic Nano Suspension – 1% W/V	1% , 10mg	-	-	Eye drops \| Suspension
Budesonide Nano Pellets	0.8 %	-	Extended Release	Capsules \| Suspension \| Tablets
Budesonide Nano Powder	0.8 %	-	-	Dry Powder Inhaler
Budesonide Nano Solution	-	-	-	Suspension
Budesonide OVB	-	-	-	Inhalation \| Oral
Budesonide SR Pellets & Nano Particles	.25% , .88% , 0.5%	-	-	-
Clarithromycin Taste Masked Pellets / Granules	27.5%, 30%, 33%, 42% & 43.75%	30#100 , 30#80	Tastemasked	Capsules \| Suspension \| Tablets
Dabigatran Pellets	35% , 40%	-	-	-
Dex Rabeprazole Pellets	8.5%,13.33%,17%, 20%	-	Delayed Release	Capsules
Dexlansoprazole DDR Pellets	17% , 20% , 22.5% , 23%	-	Dual Delayed Release	Capsules
Diclofenac Sodium SR Pellets	30% , 31.25%	-	Delayed Release	Capsules
Dipyridamole ER Pellets	42.5%	14#24	Extended Release	Capsules
Domperidone SR pellets	20%, 30%	-	Immediate Release	Capsules \| Tablets
Duloxetine HCL DR Pellets	17%, 20%	-	Delayed Release	Capsules
Erlotinib MUPs / Granules	50%	-	-	Tablets
Erlotinib Nano Particles	-	-	-	Capsules \| Injectables
Esomeprazole EC Pellets / MUPS / Granules	22.5% , 8.5%	14#18 , 16# 20 , 18#24 , 24#30 , 30#50	Delayed Release	Capsules \| Premix \| Tablets
Everolimus Granules	2.68% , 5%	-	-	Capsules \| Suspension \| Tablets

12 3

Alphabetical List of PFI Products

Product Name	Percentage	Mesh Size	Release Type	Target Formulations
Aprepitant Pellets	15% , 40%	-	Immediate Release	Capsules \| Injectables
Azithromycin MUPS & Granules	20% , 40% , 7.5%	-	Tastemasked	Capsules \| Suspension \| Tablets
Brinzolamide Opthalmic Nano Suspension – 1% W/V	1% , 10mg	-	-	Eye drops \| Suspension
Budesonide Nano Pellets	0.8 %	-	Extended Release	Capsules \| Suspension \| Tablets
Budesonide Nano Powder	0.8 %	-	-	Dry Powder Inhaler
Budesonide Nano Solution	-	-	-	Suspension
Budesonide OVB	-	-	-	Inhalation \| Oral
Budesonide SR Pellets & Nano Particles	.25% , .88% , 0.5%	-	-	-
Clarithromycin Taste Masked Pellets / Granules	27.5%, 30%, 33%, 42% & 43.75%	30#100 , 30#80	Tastemasked	Capsules \| Suspension \| Tablets
Dabigatran Pellets	35% , 40%	-	-	-
Dex Rabeprazole Pellets	8.5%,13.33%,17%, 20%	-	Delayed Release	Capsules
Dexlansoprazole DDR Pellets	17% , 20% , 22.5% , 23%	-	Dual Delayed Release	Capsules
Diclofenac Sodium SR Pellets	30% , 31.25%	-	Delayed Release	Capsules
Dipyridamole ER Pellets	42.5%	14#24	Extended Release	Capsules
Domperidone SR pellets	20%, 30%	-	Immediate Release	Capsules \| Tablets
Duloxetine HCL DR Pellets	17%, 20%	-	Delayed Release	Capsules
Erlotinib MUPs / Granules	50%	-	-	Tablets
Erlotinib Nano Particles	-	-	-	Capsules \| Injectables
Esomeprazole EC Pellets / MUPS / Granules	22.5% , 8.5%	14#18 , 16# 20 , 18#24 , 24#30 , 30#50	Delayed Release	Capsules \| Premix \| Tablets
Everolimus Granules	2.68% , 5%	-	-	Capsules \| Suspension \| Tablets

12 3

Product Name	Percentage	Mesh Size	Release Type	Target Formulations
Aprepitant Pellets	15% , 40%	-	Immediate Release	Capsules \| Injectables
Azithromycin MUPS & Granules	20% , 40% , 7.5%	-	Tastemasked	Capsules \| Suspension \| Tablets
Brinzolamide Opthalmic Nano Suspension – 1% W/V	1% , 10mg	-	-	Eye drops \| Suspension
Budesonide Nano Pellets	0.8 %	-	Extended Release	Capsules \| Suspension \| Tablets
Budesonide Nano Powder	0.8 %	-	-	Dry Powder Inhaler
Budesonide Nano Solution	-	-	-	Suspension
Budesonide OVB	-	-	-	Inhalation \| Oral
Budesonide SR Pellets & Nano Particles	.25% , .88% , 0.5%	-	-	-
Clarithromycin Taste Masked Pellets / Granules	27.5%, 30%, 33%, 42% & 43.75%	30#100 , 30#80	Tastemasked	Capsules \| Suspension \| Tablets
Dabigatran Pellets	35% , 40%	-	-	-
Dex Rabeprazole Pellets	8.5%,13.33%,17%, 20%	-	Delayed Release	Capsules
Dexlansoprazole DDR Pellets	17% , 20% , 22.5% , 23%	-	Dual Delayed Release	Capsules
Diclofenac Sodium SR Pellets	30% , 31.25%	-	Delayed Release	Capsules
Dipyridamole ER Pellets	42.5%	14#24	Extended Release	Capsules
Domperidone SR pellets	20%, 30%	-	Immediate Release	Capsules \| Tablets
Duloxetine HCL DR Pellets	17%, 20%	-	Delayed Release	Capsules
Erlotinib MUPs / Granules	50%	-	-	Tablets
Erlotinib Nano Particles	-	-	-	Capsules \| Injectables
Esomeprazole EC Pellets / MUPS / Granules	22.5% , 8.5%	14#18 , 16# 20 , 18#24 , 24#30 , 30#50	Delayed Release	Capsules \| Premix \| Tablets
Everolimus Granules	2.68% , 5%	-	-	Capsules \| Suspension \| Tablets

12 3

Product Name	Percentage	Mesh Size	Release Type	Target Formulations
Aprepitant Pellets	15% , 40%	-	Immediate Release	Capsules \| Injectables
Azithromycin MUPS & Granules	20% , 40% , 7.5%	-	Tastemasked	Capsules \| Suspension \| Tablets
Brinzolamide Opthalmic Nano Suspension – 1% W/V	1% , 10mg	-	-	Eye drops \| Suspension
Budesonide Nano Pellets	0.8 %	-	Extended Release	Capsules \| Suspension \| Tablets
Budesonide Nano Powder	0.8 %	-	-	Dry Powder Inhaler
Budesonide Nano Solution	-	-	-	Suspension
Budesonide OVB	-	-	-	Inhalation \| Oral
Budesonide SR Pellets & Nano Particles	.25% , .88% , 0.5%	-	-	-
Clarithromycin Taste Masked Pellets / Granules	27.5%, 30%, 33%, 42% & 43.75%	30#100 , 30#80	Tastemasked	Capsules \| Suspension \| Tablets
Dabigatran Pellets	35% , 40%	-	-	-
Dex Rabeprazole Pellets	8.5%,13.33%,17%, 20%	-	Delayed Release	Capsules
Dexlansoprazole DDR Pellets	17% , 20% , 22.5% , 23%	-	Dual Delayed Release	Capsules
Diclofenac Sodium SR Pellets	30% , 31.25%	-	Delayed Release	Capsules
Dipyridamole ER Pellets	42.5%	14#24	Extended Release	Capsules
Domperidone SR pellets	20%, 30%	-	Immediate Release	Capsules \| Tablets
Duloxetine HCL DR Pellets	17%, 20%	-	Delayed Release	Capsules
Erlotinib MUPs / Granules	50%	-	-	Tablets
Erlotinib Nano Particles	-	-	-	Capsules \| Injectables
Esomeprazole EC Pellets / MUPS / Granules	22.5% , 8.5%	14#18 , 16# 20 , 18#24 , 24#30 , 30#50	Delayed Release	Capsules \| Premix \| Tablets
Everolimus Granules	2.68% , 5%	-	-	Capsules \| Suspension \| Tablets

12 3

This website uses cookies and third party services. Please refer to our Privacy Policy for more information Settings Accept All Decline

Necessary Cookies

These cookies are necessary for the proper functioning of this website and better user experience. By continuing to browse this website you agree to their usage. For details please refer to our Privacy Policy.

Tracking Cookies

These cookies allows the website to remember user preferences, track user behavior across the site. The primary purpose of tracking cookies is to enable personalized experiences and website analytics.

Tracking Cookies

Third Party Embeds

The website uses Third Party Embeds to present rich media content. You can control the data collected by these third party services by selecting the choices below. If you choose not to opt in now, you may opt in when you decide to interact with the content on the website.

YouTube
Vimeo
Facebook
X
Google Maps

Title

Necessary Cookies

Tracking Cookies

Third Party Embeds